Sign up to save your podcasts
Or
Share Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Read the related article in Neurology: Neuroimmunology and Neuroinflammation.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Read the related article in Neurology: Neuroimmunology and Neuroinflammation.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
323 Listeners
Practical Neurology Podcast
46 Listeners
JAMA Clinical Reviews
494 Listeners
The Curbsiders Internal Medicine Podcast
3,319 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,084 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
512 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
351 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
364 Listeners
Continuum Audio
77 Listeners